Nonmalignant 68 Ga-FAPI-46 Uptake in 2 Cases of TENIS Syndrome : Comparison With 18 F-FDG.
The cancer specificity of fibroblast activation protein inhibitor (FAPI) uptake remains understudied topic, and several cases of false-positive FAPI PET/CT findings have been reported.
APA
Karamian F, Sadeghi R, et al. (2024). Nonmalignant 68 Ga-FAPI-46 Uptake in 2 Cases of TENIS Syndrome : Comparison With 18 F-FDG.. Clinical nuclear medicine, 49(5), e213-e214. https://doi.org/10.1097/RLU.0000000000005160
MLA
Karamian F, et al.. "Nonmalignant 68 Ga-FAPI-46 Uptake in 2 Cases of TENIS Syndrome : Comparison With 18 F-FDG.." Clinical nuclear medicine, vol. 49, no. 5, 2024, pp. e213-e214.
PMID
38465981
Abstract
The cancer specificity of fibroblast activation protein inhibitor (FAPI) uptake remains understudied topic, and several cases of false-positive FAPI PET/CT findings have been reported. We present 2 patients of differentiated thyroid cancer with thyroglobulin elevation and negative iodine scintigraphy syndrome who underwent 68 Ga-FAPI PET/CT and 18 F-FDG PET/CT for evaluation of any possible sites for metastatic disease. Although no focus of metastatic disease was found in these patients, remarkable findings were noticed instead. Nonmalignant FAPI uptake was evident in the gallbladder, uterus, and degenerative changes, whereas these uptake were discordant or partially concordant with those in FDG's, also CT images showed no underlying abnormality.
MeSH Terms
Female; Humans; Fluorodeoxyglucose F18; Positron Emission Tomography Computed Tomography; Protein Transport; Biological Transport; Gallium Radioisotopes; Neoplasms, Second Primary; Quinolines